Sam Gandy, MD, PhD
Sam Gandy, MD, PhD, is the Director of the Center for Cognitive Health and Professor of Alzheimer's disease Research as well as Professor of Neurology and Psychiatry. As Associate Director of the Mount Sinai Alzheimer's disease Research Center, he is an international authority on the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. In 1989, his team discovered the first drugs that could reduce formation of amyloid. Dr. Gandy has written more than 200 papers on this topic, and his opinions have appeared on television and in print, including the PBS Newshour, The CBS Early Show, The New York Times, New York Daily News, NBC Nightly News, and The CBS Evening News.
Martin Goldstein, MD
Director of Clinical Programs
Martin Goldstein, MD, is the Director of Clinical Programs for the Center for Cognitive Health where he oversees all patient care operations, ensuring coordinated diagnostic assessment and synergistic management across brain specialties. A graduate of Cornell University, he earned his medical degree from the State University of New York at Stony Brook. Dr. Goldstein interned in internal medicine and completed residency training in both neurology and psychiatry, all at New York Hospital‐Cornell Medical Center. He then completed fellowships in cognitive neurology at Harvard Medical School and functional brain imaging at Cornell Medical Center. He has published numerous scientific articles and book chapters, particularly on the use of fMRI to probe the neural basis of cognitive dyscontrol.
Mary Sano, PhD
Director of Research
Mary Sano, PhD, is Professor of Psychiatry, the Director of the Alzheimer's disease Research Center and the Research Director for the Center for Cognitive Health at the Icahn School of Medicine at Mount Sinai. As a world leader in clinical trial design, she assures that the Center for Cognitive Health and the whole Mount Sinai community has the opportunity to participate in cutting edge research for the detection, treatment and prevention of cognitive loss and dementia.Her research studies include the use of novel agents, repurposed drugs, surgical interventions and lifestyle and behavioral treatments and her Center has been involved in evaluating the effects of nutritional interventions, vitamins and neutraceuticals. Dr. Sano trained as a neuropsychologist and is now actively involved in designing and conducting cutting edge clinical trials for healthy aging, mild cognitive impairment and Alzheimer's disease.